Comparison of Immunogenicities of RecombinantPlasmodium vivaxMerozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed inEscherichia coli
Open Access
- 1 October 2004
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (10) , 5775-5782
- https://doi.org/10.1128/iai.72.10.5775-5782.2004
Abstract
The 42- and 19-kDa C-terminal fragments of merozoite surface protein 1 (MSP-142and MSP-119, respectively) are both promising blood-stage vaccine candidate antigens. At present, it is not clear which of the two antigens will be more suitable for inclusion in a cocktail malaria vaccine. In the present study, we expressed the two C-terminal fragments ofPlasmodium vivaxMSP-1 (PvMSP-1) in anEscherichia coliexpression system and purified them by using a rapid two-step protocol. Both of the products were recognized by monoclonal antibodies against PvMSP-1 as well as by immune sera from several individuals exposed toP. vivax. We analyzed and compared the immunological responses to recombinant PvMSP-119and PvMSP-142in mice by using six different adjuvant formulations. Moderate to high antibody responses were observed with both of the antigens in different adjuvant formulations. Surprisingly, alum, which is generally considered to be a poor adjuvant for recombinant malaria antigens, was found to be as good an adjuvant as Montanide ISA 720, ASO2A, and other adjuvant formulations. Most adjuvant formulations induced high levels of immunoglobulin G1 (IgG1), followed by IgG3 and IgG2. Lymphocytes from animals in the PvMSP-142- and PvMSP-119-immunized groups showed proliferative responses upon stimulation with the respective antigens, and high levels of interleukin-4 (IL-4), IL-5, and gamma interferon were detected in the culture supernatants. Immunodepletion studies with sera from mice immunized with these two antigens showed that while immunization with PvMSP-142does produce a PvMSP-119-specific response, a substantial portion is also focused on structures in PvMSP-142not represented by the epidermal growth factor-like domains of PvMSP-119. These findings may have implications for the design of MSP-1-based vaccine constructs.Keywords
This publication has 33 references indexed in Scilit:
- Induction of T Helper Type 1 and 2 Responses to 19-Kilodalton Merozoite Surface Protein 1 in Vaccinated Healthy Volunteers and Adults Naturally Exposed to MalariaInfection and Immunity, 2002
- Protective Immune Responses to the 42-Kilodalton (kDa) Region ofPlasmodium yoeliiMerozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa RegionInfection and Immunity, 2002
- ConferenceVaccine, 1999
- Influence of adjuvants on murine immune responses against the C‐terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein‐1 (MSP‐1)Parasite Immunology, 1996
- Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-lThe Journal of Infectious Diseases, 1996
- Advances toward the development of an asexual blood stage MSP-1 vaccine of Plasmodium vivaxMemórias do Instituto Oswaldo Cruz, 1994
- The Role of T H 1 and T H 2 Cells in a Rodent Malaria InfectionScience, 1993
- Merozoite surface antigen-I of plasmodiumParasitology Today, 1993
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.The Journal of Experimental Medicine, 1990
- Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: Functional role of IgG subclassesResearch in Immunology, 1990